London, UK, October 20, 2020 – Fairfield presents its latest report on global biodefense market, highlighting its importance in the larger scheme things. Given the state of the world, reeling under the pressure of the pandemic, the biodefense market is striving to rebuild bio-security. The impact of COVID-19 has been the highest on the market, testing its mettle through sped up research and development work and phenomenal investments.
- COVID-19 pandemic boosts biodefense market as nations assess the cost of bio warfare
- Increased investments on Anthrax to boost the product segment during the forecast period
- North America expected to lead the global market due to heavy investments and strategies adopted by this region
The global biodefense market is anticipated to grow during the forecast period as rising number of government bodies are aiming to improve development against Chemical, Biological, Radiological, and Nuclear (CBRN) threats. Rise in adoption of gene chip technologies for pathogen detection in advanced detector hardware, data base management systems, nanotechnology, and forensic division for drug related biodefense is expected to drive the global market. Rise in pervasiveness of infectious diseases such as influenza, is also one of the key reasons for rising investment for biological threats. The budget targets range of issues related to international security, national security, public health, and global healthcare.
Out of the many products, Anthrax is expected to dominate the global market as it is highly invested in by the U.S. Government to diminish the risk of Anthrax bioterrorism. The segment will likely continue dominating the market during the forecast period as it is being funded by the governments of various countries for developing and stockpiling adequate vaccine against this particular outbreak.
Rising focus on diminishing biological threats such as Zika and Ebola are also driving the market. The risk for CBRN threats due to easy availability of equipment and chemicals are forcing government bodies to prepare against them. Thus, rise in funding for the chemical threats is boosting the market growth.
North America is expected to dominate the global market as organizations in this region have undertaken strategies such as FDA, ASPR, CDC, NIAID, BARDA, and HHS. There has been remarkable investment by the U.S. civilian agencies and military for the development of biodefense solutions. This is one of the key factors for the growth of this region in the global market.
Europe is also proving lucrative opportunities to the biodefense market as the region is witnessing rise in investment for R&D activities. The investments are due to increase in threat of bioterrorism and CBRN threats. Hence, countries such as Germany and France are expected to stay ahead of the game to tackle outbreaks and contain costs related to public healthcare.
The key players operating in the global biodefense market are actively participating in adoption of new strategies to expand their customer base across the world. This aids in enlarging the brand name globally. They are actively planning strategies and launching products to meet the increasing demands to expand their footprint by adding value to their existing product portfolio.
Key players operating in the global biodefense market are SIGA Technologies, Inc., Bavarian Nordic, Altimune, Inc. (PharmAthene, Inc.), Emergent BioSolutions Inc., Cleveland Biolabs, Xoma Corporation, Dynavax Technologies Corporation, Elusys Therapeutics, Inc., B.Ichor Medical Systems, Dynport Vaccine Company LLC, Achaogen, Inc, Nanotherapeutics, Inc., Alnylam Pharmaceuticals, Inc. and others.
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.